Nonin CEO John Hastings said TruO2 OTC offers "equitable, medical-grade technology that is designed for accuracy across all ...

It is recognized for its Masimo SET Pulse Oximetry, a technology that significantly improves accuracy in measuring a patient's oxygen saturation and pulse even in the presence of motion.

Masimo Corp., whose founder Joe Kiani exited the company in late September, is focusing on fewer projects amid the separation ...

Since July, shares of Masimo have risen more than 50% to current levels around the $170 mark. Find out my recommendation for ...

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Masimo sells a range of devices used for patient monitoring that feature a proprietary pulse oximetry technology called Signal Extraction Technology (SET). In the latest update on that patent spat ...

The dispute dates to 2013 when Apple sought Masimo’s technology to install pulse oximetry on its watch. Email correspondence among Apple employees referred to Kiani as having a Steve Jobs-like ...

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Intech Investment Management LLC lessened its holdings in Masimo Co. (NASDAQ:MASI – Free Report) by 8.1% during the 3rd ...